UCLA CTSI Seminar featuring Dr. Scott Lippman
Immune Silencing is Driven by 9p Regional Genetic Loss Dictating Immune Checkpoint Inhibitor Resistance
- Date: October 12, 2022 12:00 PM - 1:00 PM
- Location: Virtual event (registration required, see description)
Los Angeles, California 90095
Scott M. Lippman, MD
Associate Vice Chancellor, Cancer Research and Care
Professor of Medicine
University of California, San Diego
Scott M. Lippman, MD, is associate vice chancellor for cancer research and care, professor of medicine at UC San Diego School of Medicine, and holds the Chugai pharmaceutical chair in cancer. He is also an adjunct professor at the Salk Institute, the Sanford-Burnham Medical Research Institute and MD Anderson Cancer Center.
Co-sponsored by the UCLA CTSI, UCLA Jonsson Comprehensive Cancer Center and the UCLA David Geffen School of Medicine Themes.